Intellipharmaceutics International Inc. announced earnings results for the second quarter ended May 31, 2021. For the second quarter, the company announced total revenue was USD 93,427 compared to USD 395,740 a year ago. Operating loss was USD 906,852 compared to USD 890,241 a year ago. Net loss was USD 1.000 million compared to USD 1.048 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.04 a year ago. For the half year, total revenue was USD 93,427 compared to USD 773,294 a year ago. Operating loss was USD 1.691 million compared to USD 2.086 million a year ago. Net loss was USD 1.924 million compared to USD 2.795 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.12 a year ago.